Q1 2018 Fate Therapeutics Inc Earnings Call
שיחת ועידה Fate Therapeutics Inc
Fate Therapeutics Inc Conference call will be held on 10/05/2018. During the earnings conference call's session Fate Therapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Fate Therapeutics Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
We are a clinicalstage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders. We are developing our product candidates based on a simple notion: we believe that better cell therapies start with better cells. Our therapeutic approach, which we refer to as cell programming, utilizes pharmacologic modulators, such as small molecules, to enhance the biological properties and therapeutic function of cells ex vivo, or outside the body. These programmed cells are then adoptively transferred to patients as therapies. We believe that this highly-differentiated therapeutic paradigm - systematically and precisely programming the biological properties and therapeutic function of cells ex vivo prior to adoptive transfer - is an elegant, cost-effective and scalable approach for maximizing the safety and efficacy of cell therapies.קרא עוד שיחת ועידה